Stop the inheritance tax perk on pensions: IFS calls for an end to retirement funds passed on tax-free and other loopholes
Is Britain workshy or in a post-Covid health crisis? UK faces a grilling from the IMF on its record 2.8m workers signed off long-term sick
I was left £5,000 short after struggling to claim my state pension - and the DWP offered just £50 to say sorry
Could you have a 50p worth £1,000? These are the Olympic coins that collectors are desperate for... including a withdrawn swimmer design from London 2012
Tax rebate agent Brooksdale enters liquidation, as customers reveal they have been waiting 10 months to get their HMRC refunds
My mortgage ends soon on my shared ownership property: Should I pay off the loan or increase my stake? DAVID HOLLINGWORTH REPLIES
Cosmetics shares are going cheap: Is now the time to beautify your portfolio with these superstar names?
Why is bitcoin halving? We explain what is happening and how the four-yearly event may affect the crypto's value
MARKET REPORT: FTSE 100 clocks up its worst week since January amid renewed market jitters over conflict in Middle East
Retail sales ground to a halt last month as shoppers turned their backs on department stores due to rising prices
Unilever waters down targets on packaging, pay and diversity amid investor backlash
L'Oreal posts better than expected sales as demand for make-up in West offsets weaker performance in Asia
US and Europe are at odds and threat of a disastrous end to era of free trade is very real, says ALEX BRUMMER
Creators of key interest rate benchmark criticise courts after failed appeal by convicted rate-rigger Tom Hayes
You may remember me as the 'disgraced fund manager': Neil Woodford is back with a blog to challenge 'consensus thinking'
INVESTING EXPLAINED: What you need to know about cocoa - and why is the price soaring?
SHARE OF THE WEEK: Wall Street investors looking for reassurance when Tesla unveils its first-quarter figures
Britain is better suited to electric cars than any of our European neighbours: New report claims two-thirds of vehicles could easily be swapped for EVs
My husband managed all my money. Now he's left me, what do I do? Money psychotherapist VICKY REYNAL replies
I want to let my flat on Airbnb while I go travelling: Will this breach my lease, mortgage and home insurance?
St James's Place paid £213K to HMRC for my inheritance tax bill - but now it's gone missing: SALLY SORTS IT
Is coin minting about to become another lost British art? asks LEE BOYCE, as Royal Mint axes overseas its currency arm as cash use plummets
Average car insurance bills rocket to almost £1,000: Costs surge £284 in a year, fuelling fears premiums are such a 'rip off' drivers avoid making claims
Is the child benefit state pension trap claiming MORE victims? Claims slump as families are forced to wait until 2026 for a 'sticking plaster' fix

Stock market report: Monday close

By Mickey Clark for MailOnline
Updated: 11:59 EDT, 10 November 2008

View
comments

Shareholders of South African miner Lonmin were today again contemplating what might have been had they agreed to the offer from earlier this year.

Movers: Latest share prices

Goldman Sachs has rubbed salt into their wounds by adding Lonmin to its influential Conviction Sell list. It warns falling production next year and a platinum-market surplus mean prices of the metal will remain low. Lonmin's earnings are, therefore, expected to slide dramatically. The broker has already cut its full-year estimates for this year to reflect the recent annual production report.

'Commodity prices represent the main risk to our estimates and target prices. The main risks for lonmin are faster volume recovery or cost deflation,' Goldman says.

In August, Xstrata launched a £5bn offer for Lonmin, which valued the platinum provider at 3300p a share. Xstrata later pulled the bid after the Lonmin board said the offer was not enough. This morning its shares were trading 96p higher at just 1187p against their peak this year of 3671p.

Just a few weeks ago, Lonmin warned about the impact of weak platinum demand, and this was behind the move by UBS to cut its rating on the shares from neutral to sell. Mining shares in general were marked higher on news of a $586bn move by China to boost its economy. Six out of the 10 best-performing blue-chips were mining companies.

Slowing demand from China has meant the mining sector has been one of the poorest stock-market performers in recent months. Xstrata rose 123p to 1191, Anglo American 156p to 1506p, and Antofagasta 23¼p to 395p. Evolution Securities questions the likely effectiveness of the fiscal stimulus and expects to see demand for commodities to remain weak with economies around the world also contracting. It has repeated its sell rating and 1820p target price on Rio Tinto, up 226p at 2844p.

However, the move by the miners also helped underpin the rest of the market, which made a positive start to the week despite shares trading below their best levels of the day. The FTSE 100 index closed 38.9 points up at 4403.9 in exceptionally thin trading. Wall Street opened sharply higher again this afternoon despite electrical retailer Circuit City filing for bankruptcy. The Dow rose 147.5 to 9091.4.

Vodafone slipped 1.6p to 108.3p following weekend reports suggesting the mobile-phone giant will use tomorrow's trading update to tell brokers their forecasts are too high. These will be the first results under new chief executive Vittorio Colao. Vodafone has seen its shares fall sharply in recent months following a slowdown in the UK and Spain. RBS has cut its target for Vodafone from 135p to 115p.

Legal & General was up ½p at 80½p following the flurry of activity in the shares that coincided with Friday night's auction, which marked the closure of official trading. A line of 2m L&G shares went through at 160p - 80p above the ruling price - prior to the auction. The London Stock Exchange promptly cancelled all the uncrossing trades in L&G that took place during the auction.

Drugs giant AstraZeneca gained 86p to 2770p after positive tests for its fatbusting drug Crestor. The study also showed the drug reduces the risk of heart attack by as much as 44% in healthy patients. Brokers say the findings could change guidelines for doctors prescribing the drug and help boost sales of statins, the class of drugs that includes Crestor. Exane BNP Paribas continues to rate astraZeneca a buy.

Keep an eye on AIM-listed West China Cement, up 11½p at 72½p, where a big buyer has been stalking the shares. The buyer is said to have taken out a stock overhang on Friday, when more than a million shares changed hands, and was back in the market place looking for stock today.

City coverage and share tips

This is Money carries breaking City news throughout the day. Bookmark Companies & Markets and try these markets links...

Tomorrow's agenda

After BT's shock profits warning earlier this month, concerns have been growing over Vodafone. First-half results will reveal whether these fears are justified. Signs are of a slowdown in Vodafone's main emerging markets, previously the major engine of growth for the group, while increased competition from rivals in Europe is expected to force down prices on the Continent. In July, Vodafone cut its relevance guidance for 2008-09 after a disappointing performance in some of its core divisions.

As the misery drags on for the construction industry, Taylor Wimpey updates the City on trading. The company is currently in discussions to refinance its £1.7bn debt mountain to avoid the risk of breaching its banking covenants. Shares in the housebuilder have fallen off a cliff in the last two years. Peaking at just over £5 in April 2007, they now change hands for just 15p.

Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence.